Market Overview

Repros Therapeutics Higher Off Positive Data For Proellex


Repros Therapeutics Inc (NASDAQ: RPRX) shares are trading higher by $0.09 at $1.97 in Tuesday's session. The issue has received a slight boost from positive clinical data for Proellex.

Following a higher open, it went a nickel higher to $2.15 before reversing course. That is just shy of a trio of highs from October 6-10 from $2.16-$2.19.

The ensuing decline has taken the issue under $2.00, so far reaching $1.93. That is just ahead of the top of Monday's range ($1.88).

The issue is attempting to close over $2.00 for the first time since October 14, when it ended the session at $2.03.

Posted-In: Technicals Intraday Update Movers Trading Ideas


Related Articles (RPRX)

View Comments and Join the Discussion!